C4 Therapeutics (CCCC.US) Latest Stock News - Major News Analysis

Event Tracking

Nov7

C4 Therapeutics released FY2025 9 Months Earnings on November 6, 2025 EST, with actual revenue of USD 24.93 M and EPS of USD -1.1813

04:00

C4 Therapeutics released FY2025 Q3 earnings on November 6, 2025 (EST), with actual revenue of USD 11.23 M (forecast USD 6.28 M) and actual EPS of USD -0.4432 (forecast USD -0.4086)

04:00

Oct16

C4 Therapeutics Announces Phase 1 Trial Data for Cemsidomide

10:37

Oct1

C4 Therapeutics demonstrates cemsidomide clinical trial progress

14:09

Aug8

C4 Therapeutics released FY2025 Semi-Annual Earnings on August 7 (EST), actual revenue USD 13.7 M, actual EPS USD -0.738

03:00

C4 Therapeutics released FY2025 Q2 earnings on August 7 (EST), actual revenue USD 6.463 M (forecast USD 6.55 M), actual EPS USD -0.37 (forecast USD -0.3925)

03:00